REYON Pharmaceutical Co., Ltd. (KRX: 102460)

REYON Pharmaceutical Revenue

REYON Pharmaceutical had revenue of 35.68B KRW in the quarter ending June 30, 2024, a decrease of -5.47%. This brings the company's revenue in the last twelve months to 148.99B, down -2.01% year-over-year. In the year 2023, REYON Pharmaceutical had annual revenue of 151.07B, down -1.93%.

• Revenue (ttm): 148.99B
• Revenue Growth: -2.01%
• P/S Ratio: 1.75
• Revenue / Employee: 319.04M
• Employees: 467
• Market Cap: 257.87B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	151.07B	-2.97B	-1.93%
Dec 31, 2022	154.04B	11.24B	7.87%
Dec 31, 2021	142.80B	12.77B	9.82%
Dec 31, 2020	130.03B	-1.52B	-1.16%
Dec 31, 2019	131.56B	8.57B	6.97%